Scholar IQ
Help
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Axel Hoos

ResearcherPublications, citations & collaboration network
318
Works
42,521
Citations
68
h-index
134
i10-index
How has Axel Hoos's publication output changed over time?
ScholarIQpublication output · 2009–2011

Output grew0% over the shown period — from 1 works in 2009 to 1 in 2011.

1
1
1
200920102011
What are the most-cited papers on Axel Hoos?
ScholarIQmost cited works
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott, Robert Weber, Jeffrey A. Sosman, John B.A.G. Haanen, René González, Caroline Robert, Dirk Schadendorf, Jessica C. Hassel, Wallace Akerley, Alfons J.M. van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia Vaübel, Gerald P. Linette, David Hogg, Christian H. Ottensmeier, Célèste Lebbé, Christian Peschel, Ian Quirt, Joseph I. Clark, Jedd D. Wolchok, Jeffrey S. Weber, Jason Tian, Michael Yellin, Geoffrey Nichol, Axel Hoos, Walter J. Urba
New England Journal of Medicine. 201015,211 CitationsOPEN ACCESS
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok
New England Journal of Medicine. 20114,475 CitationsOPEN ACCESS
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok, Axel Hoos, Steven O’Day, Jeffrey S. Weber, Omid Hamid, Célèste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol, Rachel Humphrey, F. Stephen Hodi
Clinical Cancer Research. 20093,245 Citations
Related on ScholarIQ
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Paper
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Paper
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Paper
Immunotherapy and Immune Responses
Topic
Cancer Immunotherapy and Biomarkers
Topic
Immune cells in cancer
Topic
470M+ articles · free account